Lim, S., Baker, M., Derebail, V., Chaichian, Y., Genovese, M., Rao, P., . . . Tumlin, J. (2020). Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy. BMJ Publishing Group.
Style de citation Chicago (17e éd.)Lim, Sam, et al. Phase II, Randomised, Double-blind, Multicentre Study Evaluating the Safety and Efficacy of Filgotinib and Lanraplenib in Patients with Lupus Membranous Nephropathy. BMJ Publishing Group, 2020.
Style de citation MLA (8e éd.)Lim, Sam, et al. Phase II, Randomised, Double-blind, Multicentre Study Evaluating the Safety and Efficacy of Filgotinib and Lanraplenib in Patients with Lupus Membranous Nephropathy. BMJ Publishing Group, 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.